Independent research of the leading telemedicine solutions by Frost & Sullivan has resulted in LifeBot receiving their 2014 Award for New Product Innovation Leadership for Portable Telemedicine.
To download and view the full report free click: ↓ download report
↓ view full newsletter version · ↓ download newsletter pdf file version
The Process of Research: Frost & Sullivan sent out teams of global analysts and industry experts searching for leading mobile telemedicine companies achieving dual excellence in two critical areas, Implementation Excellence and Product Excellence.
Their search concentrated on companies that not only had a vision, but that were also able to turn that vision into reality. The process included their global network of consultants, analysts, and industry peers. After an independent Board of Directors vetted their findings, one company stood out from the rest, LifeBot.
Telemedicine is the Future: It is now estimated by Deloitte’s Center for Health Solutions that telemedicine will save $500B annually in productivity.(1) Having the right patient data or information in a timely manner is critical. Telemedicine has shown it may reduce medical errors as much as 75% in treatment of trauma, as just one example.(2)
Selection of an able vendor or supplier for this demanding technology will determine if it was a good investment long term. Most will fall by the wayside, limited by the scope and breadth of their expertise; by the ways they address the real problems presented by such rapidly developing technologies in so many medical specialities. Most telemedicine solutions are already limited by performing very costly video conferencing only.(3)
Telemedicine Must Be Mobile: A new breed of mobile community paramedic is beginning to show up on the scene.(4,5) Indications are that 85% of healthcare will be done in the home or in remote clinical settings in next five or six years.(6) A paradigm shift is coming for digital health.(7)
The Mobile Micro-Hospital or Emergency Room: For these purposes the LifeBot 5 is being deployed in numerous applications. Such telemedicine solutions must be readily portable and perform a multitude of procedures in multidisciplinary fashion. They should be able to manage medical records exchange, treat the most innocuous of symptoms, but also be able to respond to serious life threatening issues, like resuscitation, yet still be rugged enough to manage care on the battlefield, or during major events or disasters.
It is for these reasons, and more, that Frost & Sullivan has awarded LifeBot the New Product Innovation Leadership Award. LifeBot CEO, Roger Heath, responded by saying, “We very much appreciate this award. We have been working very hard to build solutions that will truly be able to provide continuity of care clinically, and in mobile use, but all the way into the home. It is a dream that began here well over ten years ago, and it is still unfolding each day.”We very much appreciate this award. We have been working very hard to build solutions that will truly be able to provide continuity of care clinically, and in mobile use, but all the way into the home. It is a dream that began here well over ten years ago, and it is still unfolding each day. Roger Heath, CEO
Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which impacts both the functionality and the customer value of the new products and applications. The award lauds the high R&D spend towards innovation, its relevance to the industry and the positive impact on brand perception.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan: Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit website: www.frost.com
References:
(1) mHealth tools projected to save $500 billion in productivity by 2021, EHR Intelligence Jan. 2013.
(2) Telemedicine May Be The Answer For Rural Trauma Surgeons, Surgical Products Oct. 2009.
(3) Video Conferencing is NOT Telemedicine, Roger Lee Heath August 2011.
(4) How EMS will benefit from smartphones and connected vehicles Dia Gainor Interview ems1.com Sept. 2014.
(5) New designs for future ambulances: the Emergency Care Practitioner (ECP) BBC News, April 2013.
(6) mHealth forecast wows audience Healthcare IT News Dec. 2013.
(7) Paradigm shift coming for digital health Healthcare IT News Nov. 2014.